The review highlights the prognostic significance of various genetic lesions, such as IKZF1 deletions in BCR-ABL+ ALL and CRLF2 rearrangements in B-ALL, which are associated with poor outcomes. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.